MARKET

PODD

PODD

Insulet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

206.13
+1.46
+0.71%
After Hours: 206.13 0 0.00% 16:41 07/07 EDT
OPEN
205.61
PREV CLOSE
204.68
HIGH
212.65
LOW
203.50
VOLUME
471.97K
TURNOVER
--
52 WEEK HIGH
228.79
52 WEEK LOW
115.56
MARKET CAP
13.49B
P/E (TTM)
2554.28
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PODD stock price target is 218.60 with a high estimate of 250.00 and a low estimate of 165.00.

EPS

PODD News

More
Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares
GuruFocus.com · 1d ago
Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
Business Wire · 06/29 11:00
Insulet: A Good Time To Pick Up A Promising Stock
Seeking Alpha - Article · 06/24 13:08
Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA, will be powere
Business Wire · 06/24 10:00
Edited Transcript of PODD.OQ earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 06/21 16:13
Tandem Diabetes: Industry-Leading Innovations Support A Peak Multiple
Seeking Alpha - Article · 06/19 17:00
3 Diabetes Monitoring Companies That Are Recession-Proof
MotleyFool.com · 06/19 15:25
Medtronic next-gen closed-loop insulin system successful in U.S. trial
Seeking Alpha - Article · 06/13 14:58

Industry

Medical Equipment, Supplies & Distribution
-0.86%
Healthcare Equipment & Supplies
-0.88%

Hot Stocks

Symbol
Price
%Change

About PODD

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.
More

Webull offers kinds of Insulet Corporation stock information, including NASDAQ:PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.